查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1698058

细胞表面标记市场－全球产业规模、份额、趋势、机会和预测，按来源、产品、细胞类型、应用、地区和竞争细分，2020-2030 年

Cell Surface Markers Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Source, By Product, By Cell Type, By Application, By Region and Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 184 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

2024 年全球细胞表面标记市场价值为 7.9231 亿美元，预计在预测期内将达到 12.8517 亿美元，到 2030 年的复合年增长率为 8.37%。在基于细胞的研究、诊断和治疗技术的进步的推动下，全球细胞表面标记市场在过去几年中呈现显着成长。细胞表面标誌，也称为细胞表面抗原，是存在于细胞表面的蛋白质或糖蛋白。它们在识别和表征各种细胞类型方面发挥着至关重要的作用，这对于了解细胞功能、疾病机制和标靶治疗的开发至关重要。由于免疫学、肿瘤学、神经科学和再生医学等领域对细胞研究的需求不断增加，细胞表面标记市场一直在稳步扩大。这些标记对于区分不同细胞群、监测疾病进展和製定个人化治疗策略至关重要。

市场概览
预测期 2026-2030
2024 年市场规模 7.9231亿美元
2030年市场规模 12.8517亿美元
2025-2030 年复合年增长率 8.37％
成长最快的领域 PCR阵列
最大的市场 北美洲

主要市场驱动因素

慢性病盛行率上升推动全球细胞表面标记市场

主要市场挑战

成本限制

主要市场趋势

技术进步

目录

第 1 章：产品概述

第二章：研究方法

第 3 章：执行摘要

第四章：顾客之声

第五章：全球细胞表面标记市场展望

  • 市场规模和预测
    • 按价值
  • 市场占有率和预测
    • 按来源（小鼠、大鼠）
    • 副产品（抗体、PCR 阵列、其他）
    • 依细胞类型（B 细胞表面标誌、单核细胞表面标誌、NK 细胞表面标誌、T 细胞表面标誌）
    • 按应用（临床、研究）
    • 按地区
    • 按公司分类（2024）
  • 市场地图
    • 按来源
    • 按产品
    • 按细胞类型
    • 按应用
    • 按地区

第六章：北美细胞表面标记市场展望

  • 市场规模和预测
  • 市场占有率和预测

第七章：欧洲细胞表面标记市场展望

  • 市场规模和预测
  • 市场占有率和预测

第八章：亚太细胞表面标记市场展望

  • 市场规模和预测
  • 市场占有率和预测

第九章：南美细胞表面标记市场展望

  • 市场规模和预测
  • 市场占有率和预测

第 10 章：中东和非洲细胞表面标记市场展望

  • 市场规模和预测
  • 市场占有率和预测

第 11 章：市场动态

  • 驱动程式
  • 挑战

第 12 章：市场趋势与发展

  • 近期发展
  • 合併与收购
  • 产品发布

第 13 章：竞争格局

  • Thermo Fisher Scientific Inc.
  • QIAGEN NV
  • Becton, Dickinson and Company.
  • Danaher Corporation
  • F. Hoffmann-La Roche AG
  • Bio-Rad Laboratories, Inc
  • Abcam plc
  • GenScript Biotech Corporation
  • BioLegend, Inc.
  • Merck KGaA

第 14 章：策略建议

第15章调查会社について・免责事项

简介目录
Product Code: 17440

Global Cell Surface Markers Market was valued at USD 792.31 Million in 2024 and is expected to reach USD 1285.17 Million in the forecast period with a CAGR of 8.37% through 2030. The global cell surface markers market has been witnessing remarkable growth over the past few years, driven by advancements in cell-based research, diagnostics, and therapeutics. Cell surface markers, also known as cell surface antigens, are proteins or glycoproteins present on the surface of cells. They play a crucial role in identifying and characterizing various cell types, which is essential for understanding cellular functions, disease mechanisms, and the development of targeted therapies. The cell surface markers market has been steadily expanding, thanks to the increasing demand for cell-based research in areas such as immunology, oncology, neuroscience, and regenerative medicine. These markers are pivotal for distinguishing between different cell populations, monitoring disease progression, and developing personalized treatment strategies.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 792.31 Million
Market Size 2030USD 1285.17 Million
CAGR 2025-20308.37%
Fastest Growing SegmentPCR Arrays
Largest MarketNorth America

Key Market Drivers

Rising Prevalence of Chronic Diseases is Driving the Global Cell Surface Markers Market

Chronic diseases have become a significant global health challenge, affecting millions and straining healthcare systems worldwide. Conditions such as cancer, diabetes, cardiovascular diseases, and autoimmune disorders are on the rise, contributing to increased healthcare expenditure and reduced quality of life. In 2019, chronic diseases accounted for 74% of deaths globally, up from 67% in 2010. Specifically, diabetes has seen a dramatic increase, with over 800 million adults diagnosed worldwide, significantly higher than previous estimates. This surge underscores the urgent need for advanced diagnostic and therapeutic solutions. One such advancement is the utilization of cell surface markers, which play a pivotal role in diagnosing and treating these conditions. As the prevalence of chronic diseases continues to rise, the global cell surface markers market is experiencing robust growth.

Cell surface markers are widely used in the identification and classification of cancer cells. By analyzing the expression of specific markers on cancer cells, healthcare professionals can determine the type and stage of cancer, allowing for more personalized treatment strategies.

Key Market Challenges

Cost Constraints

Cost constraints pose a significant challenge in the global cell surface markers market, affecting both healthcare institutions and research organizations. The high cost of advanced diagnostic tools, such as flow cytometry and mass spectrometry, which rely on cell surface markers, limits accessibility for many laboratories and hospitals, particularly in developing regions. These technologies require substantial investments not only in procurement but also in maintenance, calibration, and specialized workforce training. The financial burden of acquiring and operating such sophisticated equipment creates a barrier for small- and medium-sized research facilities, restricting their ability to conduct large-scale studies or offer advanced diagnostic services.

Key Market Trends

Technological Advancements

In recent years, the healthcare and life sciences sectors have experienced remarkable technological progress that has transformed disease diagnosis, treatment, and research methodologies. A key beneficiary of these advancements is the global cell surface markers market, driven by the adoption of innovative techniques that enhance precision and efficiency in biomedical applications. Cell surface markers, also known as cluster of differentiation (CD) markers, are indispensable in cell biology, immunology, and cancer research. Flow cytometry, a fundamental technique for analyzing cell populations, has evolved with the integration of high-dimensional instruments and artificial intelligence, significantly improving data accuracy and throughput. According to the U.S. National Institutes of Health, advancements in flow cytometry have bolstered diagnostic capabilities, enabling earlier detection and better management of various diseases. These technological improvements have expanded the use of cell surface markers in both clinical and research environments, fostering new avenues for scientific exploration and therapeutic innovation.

Single-cell analysis has further revolutionized our understanding of cellular heterogeneity and disease progression. Cutting-edge technologies such as single-cell RNA sequencing and mass cytometry (CyTOF) now permit detailed profiling of individual cells, with cell surface markers serving as critical identifiers in these analyses.

Key Market Players

  • Thermo Fisher Scientific Inc.
  • QIAGEN N.V.
  • Becton, Dickinson and Company.
  • Danaher Corporation
  • F. Hoffmann-La Roche AG
  • Bio-Rad Laboratories, Inc
  • Abcam plc
  • GenScript Biotech Corporation
  • BioLegend, Inc.
  • Merck KGaA

Report Scope:

In this report, the Global Cell Surface Markers Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Cell Surface Markers Market, By Source:

  • Mice
  • Rats

Cell Surface Markers Market, By Product:

  • Antibodies
  • PCR Arrays
  • Others

Cell Surface Markers Market, By Cell type:

  • B Cell Surface Markers
  • Monocyte Cell Surface Markers
  • NK Cell Surface Markers
  • T Cell Surface Markers

Cell Surface Markers Market, By Application:

  • Clinical
  • Research

Cell Surface Markers Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Cell Surface Markers Market.

Available Customizations:

Global Cell Surface Markers market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validations
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Cell Surface Markers Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Source (Mice, Rats)
    • 5.2.2. By Product (Antibodies, PCR Arrays, Others)
    • 5.2.3. By Cell Type ( B Cell Surface Markers, Monocyte Cell Surface Markers, NK Cell Surface Markers, T Cell Surface Markers)
    • 5.2.4. By Application (Clinical, Research)
    • 5.2.5. By Region
    • 5.2.6. By Company (2024)
  • 5.3. Market Map
    • 5.3.1. By Source
    • 5.3.2. By Product
    • 5.3.3. By Cell Type
    • 5.3.4. By Application
    • 5.3.5. By Region

6. North America Cell Surface Markers Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Source
    • 6.2.2. By Product
    • 6.2.3. By Cell Type
    • 6.2.4. By Application
    • 6.2.5. By Country
      • 6.2.5.1. United States Cell Surface Markers Market Outlook
        • 6.2.5.1.1. Market Size & Forecast
        • 6.2.5.1.1.1. By Value
        • 6.2.5.1.2. Market Share & Forecast
        • 6.2.5.1.2.1. By Source
        • 6.2.5.1.2.2. By Product
        • 6.2.5.1.2.3. By Cell Type
        • 6.2.5.1.2.4. By Application
        • 6.2.5.1.2.5. By End Use
      • 6.2.5.2. Canada Cell Surface Markers Market Outlook
        • 6.2.5.2.1. Market Size & Forecast
        • 6.2.5.2.1.1. By Value
        • 6.2.5.2.2. Market Share & Forecast
        • 6.2.5.2.2.1. By Source
        • 6.2.5.2.2.2. By Product
        • 6.2.5.2.2.3. By Cell Type
        • 6.2.5.2.2.4. By Application
        • 6.2.5.2.2.5. By End Use
      • 6.2.5.3. Mexico Cell Surface Markers Market Outlook
        • 6.2.5.3.1. Market Size & Forecast
        • 6.2.5.3.1.1. By Value
        • 6.2.5.3.2. Market Share & Forecast
        • 6.2.5.3.2.1. By Source
        • 6.2.5.3.2.2. By Product
        • 6.2.5.3.2.3. By Cell Type
        • 6.2.5.3.2.4. By Application
        • 6.2.5.3.2.5. By End Use

7. Europe Cell Surface Markers Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Source
    • 7.2.2. By Product
    • 7.2.3. By Cell Type
    • 7.2.4. By Application
    • 7.2.5. By End Use
    • 7.2.6. By Country
      • 7.2.6.1. France Cell Surface Markers Market Outlook
        • 7.2.6.1.1. Market Size & Forecast
        • 7.2.6.1.1.1. By Value
        • 7.2.6.1.2. Market Share & Forecast
        • 7.2.6.1.2.1. By Source
        • 7.2.6.1.2.2. By Product
        • 7.2.6.1.2.3. By Cell Type
        • 7.2.6.1.2.4. By Application
        • 7.2.6.1.2.5. By End Use
      • 7.2.6.2. Germany Cell Surface Markers Market Outlook
        • 7.2.6.2.1. Market Size & Forecast
        • 7.2.6.2.1.1. By Value
        • 7.2.6.2.2. Market Share & Forecast
        • 7.2.6.2.2.1. By Source
        • 7.2.6.2.2.2. By Product
        • 7.2.6.2.2.3. By Cell Type
        • 7.2.6.2.2.4. By Application
        • 7.2.6.2.2.5. By End Use
      • 7.2.6.3. United Kingdom Cell Surface Markers Market Outlook
        • 7.2.6.3.1. Market Size & Forecast
        • 7.2.6.3.1.1. By Value
        • 7.2.6.3.2. Market Share & Forecast
        • 7.2.6.3.2.1. By Source
        • 7.2.6.3.2.2. By Product
        • 7.2.6.3.2.3. By Cell Type
        • 7.2.6.3.2.4. By Application
        • 7.2.6.3.2.5. By End Use
      • 7.2.6.4. Italy Cell Surface Markers Market Outlook
        • 7.2.6.4.1. Market Size & Forecast
        • 7.2.6.4.1.1. By Value
        • 7.2.6.4.2. Market Share & Forecast
        • 7.2.6.4.2.1. By Source
        • 7.2.6.4.2.2. By Product
        • 7.2.6.4.2.3. By Cell Type
        • 7.2.6.4.2.4. By Application
        • 7.2.6.4.2.5. By End Use
      • 7.2.6.5. Spain Cell Surface Markers Market Outlook
        • 7.2.6.5.1. Market Size & Forecast
        • 7.2.6.5.1.1. By Value
        • 7.2.6.5.2. Market Share & Forecast
        • 7.2.6.5.2.1. By Source
        • 7.2.6.5.2.2. By Product
        • 7.2.6.5.2.3. By Cell Type
        • 7.2.6.5.2.4. By Application
        • 7.2.6.5.2.5. By End Use

8. Asia Pacific Cell Surface Markers Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Source
    • 8.2.2. By Product
    • 8.2.3. By Cell Type
    • 8.2.4. By Application
    • 8.2.5. By End Use
    • 8.2.6. By Country
      • 8.2.6.1. China Cell Surface Markers Market Outlook
        • 8.2.6.1.1. Market Size & Forecast
        • 8.2.6.1.1.1. By Value
        • 8.2.6.1.2. Market Share & Forecast
        • 8.2.6.1.2.1. By Source
        • 8.2.6.1.2.2. By Product
        • 8.2.6.1.2.3. By Cell Type
        • 8.2.6.1.2.4. By Application
        • 8.2.6.1.2.5. By End Use
      • 8.2.6.2. India Cell Surface Markers Market Outlook
        • 8.2.6.2.1. Market Size & Forecast
        • 8.2.6.2.1.1. By Value
        • 8.2.6.2.2. Market Share & Forecast
        • 8.2.6.2.2.1. By Source
        • 8.2.6.2.2.2. By Product
        • 8.2.6.2.2.3. By Cell Type
        • 8.2.6.2.2.4. By Application
        • 8.2.6.2.2.5. By End Use
      • 8.2.6.3. South Korea Cell Surface Markers Market Outlook
        • 8.2.6.3.1. Market Size & Forecast
        • 8.2.6.3.1.1. By Value
        • 8.2.6.3.2. Market Share & Forecast
        • 8.2.6.3.2.1. By Product
        • 8.2.6.3.2.2. By Source
        • 8.2.6.3.2.3. By Product
        • 8.2.6.3.2.4. By Cell Type
        • 8.2.6.3.2.5. By Application
        • 8.2.6.3.2.6. By End Use
      • 8.2.6.4. Japan Cell Surface Markers Market Outlook
        • 8.2.6.4.1. Market Size & Forecast
        • 8.2.6.4.1.1. By Value
        • 8.2.6.4.2. Market Share & Forecast
        • 8.2.6.4.2.1. By Source
        • 8.2.6.4.2.2. By Product
        • 8.2.6.4.2.3. By Cell Type
        • 8.2.6.4.2.4. By Application
        • 8.2.6.4.2.5. By End Use
      • 8.2.6.5. Australia Cell Surface Markers Market Outlook
        • 8.2.6.5.1. Market Size & Forecast
        • 8.2.6.5.1.1. By Value
        • 8.2.6.5.2. Market Share & Forecast
        • 8.2.6.5.2.1. By Source
        • 8.2.6.5.2.2. By Product
        • 8.2.6.5.2.3. By Cell Type
        • 8.2.6.5.2.4. By Application
        • 8.2.6.5.2.5. By End Use

9. South America Cell Surface Markers Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Source
    • 9.2.2. By Product
    • 9.2.3. By Cell Type
    • 9.2.4. By Application
    • 9.2.5. By End Use
    • 9.2.6. By Country
      • 9.2.6.1. Brazil Cell Surface Markers Market Outlook
        • 9.2.6.1.1. Market Size & Forecast
        • 9.2.6.1.1.1. By Value
        • 9.2.6.1.2. Market Share & Forecast
        • 9.2.6.1.2.1. By Product
        • 9.2.6.1.2.2. By Indication
        • 9.2.6.1.2.3. By Source
        • 9.2.6.1.2.4. By End Use
      • 9.2.6.2. Argentina Cell Surface Markers Market Outlook
        • 9.2.6.2.1. Market Size & Forecast
        • 9.2.6.2.1.1. By Value
        • 9.2.6.2.2. Market Share & Forecast
        • 9.2.6.2.2.1. By Source
        • 9.2.6.2.2.2. By Product
        • 9.2.6.2.2.3. By Cell Type
        • 9.2.6.2.2.4. By Application
        • 9.2.6.2.2.5. By End Use
      • 9.2.6.3. Colombia Cell Surface Markers Market Outlook
        • 9.2.6.3.1. Market Size & Forecast
        • 9.2.6.3.1.1. By Value
        • 9.2.6.3.2. Market Share & Forecast
        • 9.2.6.3.2.1. By Source
        • 9.2.6.3.2.2. By Product
        • 9.2.6.3.2.3. By Cell Type
        • 9.2.6.3.2.4. By Application
        • 9.2.6.3.2.5. By End Use

10. Middle East & Africa Cell Surface Markers Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Source
    • 10.2.2. By Product
    • 10.2.3. By Cell Type
    • 10.2.4. By Application
    • 10.2.5. By End Use
    • 10.2.6. By Country
      • 10.2.6.1. South Africa Cell Surface Markers Market Outlook
        • 10.2.6.1.1. Market Size & Forecast
        • 10.2.6.1.1.1. By Value
        • 10.2.6.1.2. Market Share & Forecast
        • 10.2.6.1.2.1. By Source
        • 10.2.6.1.2.2. By Product
        • 10.2.6.1.2.3. By Cell Type
        • 10.2.6.1.2.4. By Application
        • 10.2.6.1.2.5. By End Use
      • 10.2.6.2. Saudi Arabia Cell Surface Markers Market Outlook
        • 10.2.6.2.1. Market Size & Forecast
        • 10.2.6.2.1.1. By Value
        • 10.2.6.2.2. Market Share & Forecast
        • 10.2.6.2.2.1. By Source
        • 10.2.6.2.2.2. By Product
        • 10.2.6.2.2.3. By Cell Type
        • 10.2.6.2.2.4. By Application
        • 10.2.6.2.2.5. By End Use
      • 10.2.6.3. UAE Cell Surface Markers Market Outlook
        • 10.2.6.3.1. Market Size & Forecast
        • 10.2.6.3.1.1. By Value
        • 10.2.6.3.2. Market Share & Forecast
        • 10.2.6.3.2.1. By Source
        • 10.2.6.3.2.2. By Product
        • 10.2.6.3.2.3. By Cell Type
        • 10.2.6.3.2.4. By Application
        • 10.2.6.3.2.5. By End Use

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Development
  • 12.2. Mergers & Acquisitions
  • 12.3. Product Launches

13. Competitive Landscape

  • 13.1. Thermo Fisher Scientific Inc.
    • 13.1.1. Business Overview
    • 13.1.2. Application Offerings
    • 13.1.3. Recent Developments
    • 13.1.4. Key Personnel
    • 13.1.5. SWOT Analysis
  • 13.2. QIAGEN N.V.
  • 13.3. Becton, Dickinson and Company.
  • 13.4. Danaher Corporation
  • 13.5. F. Hoffmann-La Roche AG
  • 13.6. Bio-Rad Laboratories, Inc
  • 13.7. Abcam plc
  • 13.8. GenScript Biotech Corporation
  • 13.9. BioLegend, Inc.
  • 13.10.Merck KGaA

14. Strategic Recommendations

15. About us & Disclaimer